Prevention of NAFLD and CVD Through Lifestyle Intervention
Recruiting · NCT05618626 · Interventional (participants receive a specific treatment) · Lead sponsor: Pontificia Universidad Catolica de Chile
View the official record on ClinicalTrials.gov →Interventions studied
Physical exercise and dietary intervention for NAFLD
What this trial is about
Prevention of non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) through lifestyle intervention (MAUCO+) is a clinical trial that aims to improve sarcopenia, aerobic capacity, body composition, and lipid profile, insulin resistance, cardiovascular risk, NAFLD, and maintain a healthier lifestyle. Through the implementation of physical activity and nutritional programs.
Who can take part
Age range
45 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- With and without gallstones disease
- With various degrees of NAFLD (none too severe)
Exclusion criteria
- Any significant comorbidity or physical limitation to undergo resistance exercise program
- Use of medications that alter muscle mass (e.g., corticosteroids)
- History of hepatitis B or C
- Use of hepatotoxic drugs
Where it is running
1 location listed.
- Centro MAUCO+ - Molina, Maule Region, Chile